These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 39260927)
1. Effect of Evogliptin on the Progression of Aortic Valvular Calcification. Song JK; Lee S; Kim YJ; Kim HK; Ha JW; Choi EY; Park SW; Park SJ; Park YH; Park JH; Yang DH; Kim KH; Yang DH; Han S; Chae SY; Lee JS; Song JM; Cho GY J Am Coll Cardiol; 2024 Sep; 84(12):1064-1075. PubMed ID: 39260927 [TBL] [Abstract][Full Text] [Related]
2. Bicuspid Aortic Valve Stenosis and the Effect of Vitamin K2 on Calcification Using Peeters FECM; van Mourik MJW; Meex SJR; Bucerius J; Schalla SM; Gerretsen SC; Mihl C; Dweck MR; Schurgers LJ; Wildberger JE; Crijns HJGM; Kietselaer BLJH Nutrients; 2018 Mar; 10(4):. PubMed ID: 29561783 [TBL] [Abstract][Full Text] [Related]
3. Evogliptin Suppresses Calcific Aortic Valve Disease by Attenuating Inflammation, Fibrosis, and Calcification. Choi B; Kim EY; Kim JE; Oh S; Park SO; Kim SM; Choi H; Song JK; Chang EJ Cells; 2021 Jan; 10(1):. PubMed ID: 33401457 [TBL] [Abstract][Full Text] [Related]
9. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. Cowell SJ; Newby DE; Prescott RJ; Bloomfield P; Reid J; Northridge DB; Boon NA; N Engl J Med; 2005 Jun; 352(23):2389-97. PubMed ID: 15944423 [TBL] [Abstract][Full Text] [Related]
10. 18F-sodium fluoride uptake is a marker of active calcification and disease progression in patients with aortic stenosis. Dweck MR; Jenkins WS; Vesey AT; Pringle MA; Chin CW; Malley TS; Cowie WJ; Tsampasian V; Richardson H; Fletcher A; Wallace WA; Pessotto R; van Beek EJ; Boon NA; Rudd JH; Newby DE Circ Cardiovasc Imaging; 2014 Mar; 7(2):371-8. PubMed ID: 24508669 [TBL] [Abstract][Full Text] [Related]
11. Aortic stenosis, atherosclerosis, and skeletal bone: is there a common link with calcification and inflammation? Dweck MR; Khaw HJ; Sng GK; Luo EL; Baird A; Williams MC; Makiello P; Mirsadraee S; Joshi NV; van Beek EJ; Boon NA; Rudd JH; Newby DE Eur Heart J; 2013 Jun; 34(21):1567-74. PubMed ID: 23391586 [TBL] [Abstract][Full Text] [Related]
12. Effects of menaquinone-7 supplementation in patients with aortic valve calcification: study protocol for a randomised controlled trial. Lindholt JS; Frandsen NE; Fredgart MH; Øvrehus KA; Dahl JS; Møller JE; Folkestad L; Urbonaviciene G; Becker SW; Lambrechtsen J; Auscher S; Hosbond S; Alan DH; Rasmussen LM; Gerke O; Mickley H; Diederichsen A BMJ Open; 2018 Aug; 8(8):e022019. PubMed ID: 30139903 [TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of evogliptin monotherapy in patients with type 2 diabetes and moderately elevated glycated haemoglobin levels after diet and exercise. Park J; Park SW; Yoon KH; Kim SR; Ahn KJ; Lee JH; Mok JO; Chung CH; Han KA; Koh GP; Kang JG; Lee CB; Kim SH; Kwon NY; Kim DM Diabetes Obes Metab; 2017 Dec; 19(12):1681-1687. PubMed ID: 28448688 [TBL] [Abstract][Full Text] [Related]
19. Lipoprotein(a) has no major impact on calcification activity in patients with mild to moderate aortic valve stenosis. Kaiser Y; Nurmohamed NS; Kroon J; Verberne HJ; Tzolos E; Dweck MR; Somsen AG; Arsenault BJ; Stroes ESG; Zheng KH; Boekholdt SM Heart; 2022 Jan; 108(1):61-66. PubMed ID: 34593533 [TBL] [Abstract][Full Text] [Related]
20. De Azevedo D; Geers J; Gheysens O; Dweck M; Vancraeynest D Semin Nucl Med; 2023 Mar; 53(2):241-257. PubMed ID: 36116988 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]